Literature DB >> 25060277

Consanguinity and polygenic diseases: a model for antibody deficiencies.

Valentina Di Pierro1, Roberta Zuntini, Caterina Cancrini, Andrea Finocchi, Giulia Angelino, Paolo Rossi, Simona Ferrari.   

Abstract

Primary immunodeficiencies represent a heterogeneous group of disorders of the immune system, predisposing to various types of infections. Among them, common variable immunodeficiency is the most common symptomatic antibody deficiency. It includes several different forms characterized by defects in the terminal stage of B lymphocyte differentiation, leading to markedly reduced immunoglobulin serum levels and increased susceptibility to bacterial infections. The clinical phenotype is complex, including autoimmunity, granulomatous inflammation, lymphoproliferative disorders and malignancies. Rare autosomal recessive mutations in a number of single genes have recently been reported. However, the underlying genetic defects remain unknown in the majority of cases. In order to seek new genes responsible for the disease, we studied a consanguineous Italian family through exome sequencing combined with homozygosity mapping. Six missense homozygous variants passed our filtering selection and at least two of them were associated with some aspects of the pathological phenotype. Our data remark the complexity of immune system disorders and emphasize the difficulty to understand the significance of genetic results and their correlation with the disease phenotype.
© 2014 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2014        PMID: 25060277     DOI: 10.1159/000362364

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  1 in total

1.  A cross-sectional survey of multi-generation inflammatory bowel disease consanguinity and its relationship with disease onset.

Authors:  Mahmoud Mosli; Abdulelah Alzahrani; Showlag Showlag; Abdullah Alshehri; Ahmed Hejazi; Majed Alnefaie; Adel Almaymuni; Mubarak Abdullahi; Mohammed Albeshir; Eman Alsulais; Hani Jawa; Emad Aljahdli; Salem Bazarah; Yousif Qari
Journal:  Saudi J Gastroenterol       Date:  2017 Nov-Dec       Impact factor: 2.485

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.